BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24641956)

  • 1. Mesenchymal stem cell-based therapy for type 1 diabetes.
    Wu H; Mahato RI
    Discov Med; 2014 Mar; 17(93):139-43. PubMed ID: 24641956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
    Bhonde RR; Sheshadri P; Sharma S; Kumar A
    Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Int Immunopharmacol; 2017 Mar; 44():191-196. PubMed ID: 28110219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of mesenchymal stromal cells in pancreatic islet transplantation.
    Hematti P; Kim J; Stein AP; Kaufman D
    Transplant Rev (Orlando); 2013 Jan; 27(1):21-9. PubMed ID: 23290684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.
    de Lima KA; de Oliveira GL; Yaochite JN; Pinheiro DG; de Azevedo JT; Silva WA; Covas DT; Couri CE; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KC
    Stem Cell Res Ther; 2016 Jul; 7(1):92. PubMed ID: 27406064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro.
    Davies LC; Alm JJ; Heldring N; Moll G; Gavin C; Batsis I; Qian H; Sigvardsson M; Nilsson B; Kyllonen LE; Salmela KT; Carlsson PO; Korsgren O; Le Blanc K
    Stem Cells Transl Med; 2016 Nov; 5(11):1485-1495. PubMed ID: 27412884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
    Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
    Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy to cure type 1 diabetes: from hype to hope.
    Chhabra P; Brayman KL
    Stem Cells Transl Med; 2013 May; 2(5):328-36. PubMed ID: 23572052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.
    Forostyak S; Jendelova P; Sykova E
    Biochimie; 2013 Dec; 95(12):2257-70. PubMed ID: 23994163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study.
    Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL
    Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes.
    Lee HJ; Jung J; Cho KJ; Lee CK; Hwang SG; Kim GJ
    Differentiation; 2012 Oct; 84(3):223-31. PubMed ID: 22885322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
    Gerace D; Martiniello-Wilks R; Nassif NT; Lal S; Steptoe R; Simpson AM
    Stem Cell Res Ther; 2017 Mar; 8(1):62. PubMed ID: 28279194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.